This site is intended for healthcare professionals

Merck Inc., announces voluntary licensing agreements with five Indian generics manufacturers to accelerate access to molnupiravir, an investigational oral therapeutic for the treatment of COVID-19.

Read time: 1 mins
Last updated:29th Apr 2021
Published:29th Apr 2021
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest